EP3138916
Ónæmisvaldandi samsetning
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
25.5.2012EP published:
19.6.2019EP application number:
16193340.3
EP translation filed:
19.8.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
24.5.2032Expiry date:
24.5.2024
Title:
IMMUNOGENIC COMPOSITION
Timeline
Today
25.5.2012EP application
19.6.2019EP Publication
19.8.2019Translation submitted
15.9.2019Registration published
24.5.2024Expires
Owner
Name:
GlaxoSmithKline Biologicals S.A.Address:
Rue de l'Institut 89, 1330, Rixensart, BE
Inventor
Name:
CASTADO, CindyAddress:
Rixensart, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161490707 PDate:
27.5.2011Country:
US
Number:
201161490734 PDate:
27.5.2011Country:
US
Number:
201161490716 PDate:
27.5.2011Country:
US
Classification
Categories:
C12N 15/62, C07K 14/33, A61K 39/08
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 14.4.2020
Expires: 24.5.2021
Payer: Örn Þór slf.
Number: 10
Paid: 21.4.2021
Expires: 24.5.2022
Payer: Patice ehf.
Number: 11
Paid: 19.4.2022
Expires: 24.5.2023
Payer: Patice ehf.
Number: 12
Paid: 22.4.2023
Expires: 24.5.2024
Payer: Árnason Faktor ehf.